A股異動丨北陸藥業大跌超8% 年度業績穩步增長 因疫情影響一季度淨利預降
格隆匯3月12日丨北陸藥業(300016.SZ)今日大幅低開下跌,盤中一度觸及跌停。現報10.23元,跌8.58%,暫成交2.32億元,最新總市值50.61億元。北陸藥業昨日公佈,2019年實現淨利潤3.42億元,同比增長131.75%,擬10派0.7元。同時發佈2020年一季度盈警,淨利預降10%-40%。受新冠肺炎疫情影響,全國各地醫院積極抗擊疫情,部分醫院至今仍未恢復正常門診,門診量、檢測量、手術量等均大幅下降,藥品銷售終端需求受到明顯影響;此外,物流運輸受到一定程度管控,也導致公司業績較去年同期有所下降。市場人士指,公司2019年度業績穩步上升,但受到肺炎疫情的持續影響,今年上半年公司增長或受制約。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.